Abstract
The level of topoisomerase I mRNA was measured in cells of two mouse lymphoma (LY) sublines treated with db-cAMP. A transient increase of the level was observed to be of about 60% of the basic level and to have maximum after the 3 h treatment of LY-S cells. The increase in LY-R subline was two-fold lower. The activity of PKA in a cytosol fraction of LY-S cells was 1.75 times higher than that in LY-R cells. The activity of PKA in membranes and nuclear fraction did not differ significantly in both cell types. When the activity of PKA in LY-S cells was inhibited with H8, no increase of the level of topoisomerase I mRNA was observed upon db-cAMP treatment of cells. We suggest that the activity of PKA in the cytosol controls the expression of topoisomerase I gene in LY cells at high concentration of cAMP.
Similar content being viewed by others
Abbreviations
- db-cAMP:
-
dibutyryl-cAMP
- H8:
-
N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide
- LY:
-
mouse L5178Y lymphoma
- PKA:
-
protein kinase A
- topo I:
-
topoisomerase I
References
Heck M & Earnshaw WC (1988) In: Varner JE (Ed) Self-Assembling Architecture (pp 243–263) Alan R Liss, New York
Romig H & Richter A (1990) Biochim Biophys Acta 1048:274–280
Sobczak J, Tournier M-F, Lotti A-M & Duguet M (1989) Eur J Biochem 180:49–53
Romig H & Richter A (1990) Nucleic Acids Res 18:801–808
Hwong C-L, Chen M-S & Hwang J (1989) J Biol Chem 264: 14923–14926
Kunze N, Klein M, Richter A & Knippers R (1990) Eur J Biochem 194:323–330
Mattern MR, Nambi P, O'Leary BJ, Mirabelli CK, Crooke ST & Johnson RK (1991) Receptor 1:181–190
Staron K & Wozny W (1992) Int J Biochem 24:1717–1720
Jungmann RA, Kelley DC, Miles MF & Milkowski DM (1983) J Biol Chem 258:5312–5318
Hod Y & Hanson R (1988) J Biol Chem 263:7747–7752
Boney C, Fink D, Schlichter D, Carr K & Wicks WD (1983) J Biol Chem 258:4911–4918
Choi H-S, Li B, Lin Z, Huang E & Liu AY-C (1991) J Biol Chem 266:11858–11865
Cool DR, Leibach FH, Bhalla VK, Mahesh VB & Ganapathy V (1991) J Biol Chem 266:15750–15757
Budzicka E, Niepokojczycka E & Szumiel I (1981) Neoplasma 28:423–433
Chomczynski P & Sacchi N (1987) Anal Biochem 162:156–159
Oddou P, Schmidt U, Knippers R & Richter A (1988) Eur J Biochem 177:523–529
Gunning P, Okayama H, Engle J, Blau H & Kedes L (1983) Mol Cell Biol 3:787–795
Maniatis T, Fritsch EF & Sambrook J (1989) Molecular Cloning: a Laboratory Manual Cold Spring Harbor, New York
Tan KB, Per SR, Boyce RA & Mirabelli CK (1988) Biochem Pharmacol 37:4413–4416
Rijksen G, van Oirschot BA & Staal GEJ (1991) Methods Enzymol 200:107–111
Enamoto T, Tanuma S & Jamada M (1983) Biochemistry 22:1128–1133
Nakamura T, Datta R, Sherman ML & Kufe D (1990) J Biol Chem 265:22011–22015
Sakaue M & Hoffman BB (1991) J Biol Chem 266:5743–5749
Hidaka H, Inagaki M, Kawamoto S & Sasaki Y (1984) Biochemistry 23:5036–5041
Tse-Dinh Y-C, Wong TW & Goldberg AR (1984) Nature 312:785–786
Samels DS & Shimuzu N (1992) J Biol Chem 267:11156–11162
Pommier Y, Kerrigan D, Hartman KD & Glazer RI (1990) J Biol Chem 265:9418–9422
Karin M (1992) FASEB J 6:2581–2590
Alexander P & Mikulski, ZB (1961) Nature 192:572–573
Kowalska-Loth B, Staron K, Buraczewska I, Szumiel I, Kapiszewska M & Lange, CS (1993) Biochim Biophys Acta 1172:117–123
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Czerwinski, R.M., Nieznanski, K., Sochanowicz, B. et al. PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP. Mol Biol Rep 19, 93–97 (1994). https://doi.org/10.1007/BF00997153
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00997153